Cyclosporine suppresses hepatitis C virus and increases the chance of a sustained virological response after liver transplantation
6th Jan 2006, 04:17 GMT
Liver transplant patients with hepatitis C virus (HCV) achieved significantly better long-term viral response when taking the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination therapy. Cyclosporine also showed efficacy against Hepatitis C virus in vitro.
Cyclosporine suppresses hepatitis C virus and increases the chance of a sustained virological response after liver transplantation related news:
- Cyclosporine inhibits hepatitis C virus in vitro — EurekAlert! - Medicine and Health
- Cyclosporine Shows Advantage Over Tacrolimus — RedOrbit News - Health
- REVIEW ARTICLE: Medical Progress: Autoimmune Hepatitis — New England Journal of Medicine -- Recent Issues
- Volume 42, number 3: Severe or Fatal Liver Injury in 50 Patients in the United States Taking Rifampbin and Pyrazinamide for Latent Tuberculosis Infection — Clin Infect Dis Latest Issue
- Study Shows Importance of Immune Response in Liver Disease — RedOrbit News - Health
- CDC Updates Guidelines for Immunization Against Hepatitis B Virus Infection — Medscape Med Students Headlines
- Understanding fatigue in chronic liver disease — EurekAlert! - Medicine and Health
- New Pathways Link Liver Disease To Changes In The Central Nervous System — ScienceDaily Headlines
- Preventing The Harmful Immune Response To Newly Transplanted Organs — Medical News Today RSS/XML Feed
- Viral Hepatitis Conference to Take Place February 27-28, 2006 in Boston, MA — RedOrbit News - Health
Latest news from News-Medical News Feed:
- Children being set up for heart disease later on in life
- New cancer treatments use body's own immune system to kill melanoma tumours
- IVF success compromised by heavy smoking
- Why we all carry on with those bad habits
- Sugar and fizzy drinks linked to pancreatic cancer
- SpectraScience files new patent application
- Global Patient Safety Challenge: Clean Care is Safer Care
- FDA strengthens program for medical devices
- Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer
- More U.S residents trust TV for health info